JP2022553077A5 - - Google Patents
Info
- Publication number
- JP2022553077A5 JP2022553077A5 JP2022523855A JP2022523855A JP2022553077A5 JP 2022553077 A5 JP2022553077 A5 JP 2022553077A5 JP 2022523855 A JP2022523855 A JP 2022523855A JP 2022523855 A JP2022523855 A JP 2022523855A JP 2022553077 A5 JP2022553077 A5 JP 2022553077A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- halo
- phenyl
- independently selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962923936P | 2019-10-21 | 2019-10-21 | |
| US62/923,936 | 2019-10-21 | ||
| PCT/IB2020/001135 WO2021079196A2 (en) | 2019-10-21 | 2020-10-20 | Mettl3 modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022553077A JP2022553077A (ja) | 2022-12-21 |
| JP2022553077A5 true JP2022553077A5 (enExample) | 2023-10-30 |
Family
ID=73856560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523855A Pending JP2022553077A (ja) | 2019-10-21 | 2020-10-20 | Ｍｅｔｔｌ３モジュレーター |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230027361A1 (enExample) |
| EP (1) | EP4048674A2 (enExample) |
| JP (1) | JP2022553077A (enExample) |
| CN (1) | CN115298179A (enExample) |
| AU (1) | AU2020372002A1 (enExample) |
| WO (1) | WO2021079196A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022074391A1 (en) * | 2020-10-08 | 2022-04-14 | Storm Therapeutics Limited | Compounds inhibitors of mettl3 |
| CN113234079B (zh) * | 2021-04-30 | 2022-02-01 | 上海湃隆生物科技有限公司 | 用作prmt5抑制剂的核苷类似物 |
| CN114032311A (zh) * | 2021-12-24 | 2022-02-11 | 山东大学齐鲁医院 | Mettl3在aml化疗耐药性中的应用 |
| EP4477654A4 (en) * | 2022-02-11 | 2026-05-20 | Xizang Haisco Pharmaceutical Co Ltd | METTL3 INHIBITOR AND COMPOSITION, AND THEIR APPLICATION IN MEDICINE |
| CN115850280B (zh) * | 2022-12-08 | 2024-07-05 | 南京康立瑞生物科技有限公司 | 一种抗病毒药恩替卡韦中间体n4的制备方法 |
| US12091400B2 (en) | 2023-01-20 | 2024-09-17 | Epics Therapeutics | Piperidine derivatives as METTL3 inhibitors |
| EP4688768A1 (en) | 2023-03-30 | 2026-02-11 | Novalix | Novel mettl3 inhibitors and use thereof in therapy |
| WO2025049624A1 (en) * | 2023-08-29 | 2025-03-06 | Purdue Research Foundation | Prodrugs of nicotinamide n-methyltransferase (nnmt) inhibitors and uses thereof |
| WO2025106014A1 (en) * | 2023-11-14 | 2025-05-22 | Engine Biosciences Pte. Ltd. | Compounds and methods for pkmyt1 inhibition |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI791251B (zh) * | 2015-08-26 | 2023-02-01 | 比利時商健生藥品公司 | 使用作為ｐｒｍｔ５抑制劑之新穎經６-６雙環芳香環取代之核苷類似物 |
| EA201990851A1 (ru) * | 2017-02-24 | 2019-09-30 | Янссен Фармацевтика Нв | Новые аналоги карбануклеозида, замещенные моноциклической и бициклической кольцевой системой, для применения в качестве ингибиторов prmt5 |
| AU2018313910B2 (en) * | 2017-08-09 | 2022-12-08 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (PRMT5) |
| SG11202005112TA (en) * | 2017-12-05 | 2020-06-29 | Angex Pharmaceutical Inc | Heterocyclic compounds as prmt5 inhibitors |
| CA3134613A1 (en) * | 2019-04-02 | 2020-10-08 | Aligos Therapeutics, Inc. | Compounds targeting prmt5 |
-
2020
- 2020-10-20 JP JP2022523855A patent/JP2022553077A/ja active Pending
- 2020-10-20 AU AU2020372002A patent/AU2020372002A1/en not_active Abandoned
- 2020-10-20 EP EP20862016.1A patent/EP4048674A2/en not_active Withdrawn
- 2020-10-20 WO PCT/IB2020/001135 patent/WO2021079196A2/en not_active Ceased
- 2020-10-20 CN CN202080088790.7A patent/CN115298179A/zh active Pending
- 2020-10-20 US US17/770,708 patent/US20230027361A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022552873A5 (enExample) | ||
| JP2021534124A5 (enExample) | ||
| JP2016509583A5 (enExample) | ||
| JP2016172739A5 (enExample) | ||
| JP2022544714A5 (enExample) | ||
| JP2012529535A5 (enExample) | ||
| RU2012156940A (ru) | Лекарственные средства, индуцирующие апоптоз, для лечения рака и иммунных и аутоиммунных заболеваний | |
| JP2013521291A5 (enExample) | ||
| JP2024519487A5 (enExample) | ||
| JP2016514719A5 (enExample) | ||
| JP2016520131A5 (enExample) | ||
| RU2018120318A (ru) | ИМИДАЗО[4,5-c]ХИНОЛИН-2-ОНОВЫЕ СОЕДИНЕНИЯ И ИХ ПРИМЕНЕНИЕ В ЛЕЧЕНИИ РАКА | |
| RU2014110623A (ru) | Пирролопиразиновые ингибиторы киназы | |
| JP2017519754A5 (enExample) | ||
| JP2016514718A5 (enExample) | ||
| JP2023533203A5 (enExample) | ||
| JP2016526576A5 (enExample) | ||
| JP2023531709A5 (enExample) | ||
| JP2014510147A5 (enExample) | ||
| JP2020531593A5 (enExample) | ||
| JP2021523168A5 (enExample) | ||
| JP2017531677A5 (enExample) | ||
| JP2022509206A5 (enExample) | ||
| JP2020521766A5 (enExample) | ||
| JP2022501334A5 (enExample) |